Pharmafile Logo
Pharmafocus logo
Advanced Search
Humira image

AbbVie’s Humira meets endpoint in eye disease study

May 6, 2015
Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis

In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …

News
sarret

New chief business officer for Corium

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium

Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer. 

Appointment
china_flag

Chinese government to lift drug price controls

May 5, 2015
Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government

The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …

News
bayer_chimney

Bayer buys blood-thinning drug from Isis

May 5, 2015
Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …

News
Keytruda image

Worldwide cancer spending tops $100 billion

May 5, 2015
Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology

Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …

News
Novo image

Novo Nordisk invests in haemophilia with Denmark facility

May 5, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven

Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …

News
Jonathan Day

Working Life: AstraZeneca’s Jonathan Day

May 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Jonathan Day, Working Life

 How did you find your way into your current role? By way of background, I trained in medicine at the …

Feature
agata

Two consultants join RSA’s UK team

May 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agata Grzeszczuk, Andy Theodorou, rsa

Life sciences recruitment firm RSA has appointed two new consultants to its UK executive search team.   Agata Grzeszczuk (pictured) takes …

Appointment
Actos image

Takeda pays $2.7 billion to settle Actos lawsuits

May 1, 2015
Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2

Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

News
singapore

Martindale Pharma expands business in Asia-Pacific

May 1, 2015
Manufacturing and Production, Sales and Marketing Singapore, aft pharma, martindale

UK-based speciality firm Martindale Pharma is to expand its business in the Asia-Pacific market with the appointment of AFT Pharmaceuticals …

News
Breo image

GSK sees FDA clearance for asthma drug

May 1, 2015
Sales and Marketing Breo Ellipta, FDA, GSK, Theravance

GlaxoSmithKline and Theravance’s Breo Ellipta inhaler has been approved by the FDA to treat asthma in adults. Whilst the once-daily treatment …

News
kirtsy_virgo

Virgo Consumer Health & Wellbeing hires associate director

May 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kirsty McKinnon, Virgo

Virgo Consumer Health & Wellbeing has appointed Kirsty McKinnon to lead the division’s personal care sector. McKinnon joins the firm …

Appointment
Bayer image

Profits fall at Bayer but new drugs see growth

May 1, 2015
Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban

Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …

News
apple_research_kit_presented_by_senior_vp_of_operations_jeff_williams_

Apple research apps to require ethics board approval

April 30, 2015
Sales and Marketing Apple, BMJ, FDA, GP, researchkit

New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …

News
Perrigo image

Perrigo bats away raised Mylan bid

April 30, 2015
Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger

Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

News
NHS image

NHS ‘close to breaking point’

April 30, 2015
Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund

England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …

News
abilify_bms_otsuka

FDA waves through generic BMS antipsychotic

April 30, 2015
Manufacturing and Production, Sales and Marketing Alembic, BMS, FDA, Hetero and Torrent Pharmaceuticals, Teva

The FDA has approved four generic versions of Bristol-Myers Squibb’s top selling Abilify, an atypical antipsychotic drug approved to treat …

News
giorgio_bruno

Recipharm appoints general manager for Italian unit

April 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Giorgio Bruno, Recipharm

Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …

Appointment

Pharma accused of hiding behind regulation and undermining NICE

April 29, 2015
Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma

University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …

News
pfizer_building_side

Pfizer posts second consecutive quarterly income decline

April 29, 2015
Sales and Marketing 2015, Pfizer, Q1, first quarter

Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …

News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026